BRIEF-Cytokinetics announces orphan drug designation for CK-2127107 for treatment of spinal muscular atrophy

* Cytokinetics announces orphan drug designation for CK-2127107 for the treatment of spinal muscular atrophy
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.